A real world study assessing efficacy of carfilzomib-based regimens in patients with relapsed/refractory multiple myeloma
Latest Information Update: 08 Aug 2021
At a glance
- Drugs Carfilzomib (Primary) ; Dexamethasone (Primary) ; Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 08 Aug 2021 New trial record
- 17 Jun 2021 Results presented at the 26th Congress of the European Haematology Association